• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

World Market for Prescription Respiratory Drugs, The

$3,500.00 – $7,000.00

Clear
SKU: KLI1190854 Category: Pharmaceuticals Market Research Pages: 168
  • Description
  • Table of Contents
  • Latest reports

Description

The global market for prescription respiratory drugs encompasses a wide variety of products that treat both common everyday respiratory illnesses as well as serious chronic conditions such as COPD. Technological developments and improved delivery methods have given many health professionals a wider range of products to treat patients with respiratory diseases and have expanded the market for respiratory pharmaceuticals.

This comprehensive study of the market for prescription pharmaceutical products to treat respiratory illness examines six distinct drug segments:

  • Anti-inflammatories, Inhaled Corticosteroids
  • Mast Stabilizers, Leukotriene Modifiers, and Other Biologics
  • Antihistamines, Decongestants, and Antitussives
  • Bronchodilators
  • Lung Fluid Replacement and Mucokinetic Agents
  • Other Respiratory Drugs

Each section provides particulars on the currently available pharmaceutical products in that class, the development pipeline (including developer and development stage), and detailed market data on the segment, including:

  • Historical revenue performance 2000-2005
  • Revenue projections through 2010
  • Geographic revenue breakdown (U.S. vs non-U.S.)
  • Epidemiology of the relevant conditions
  • Revenues and market shares of the leading suppliers.

The report also reviews the major drivers and constraints in the respiratory drug market as well as the issues and trends in healthcare more generally that will impact this segment in the coming years and profiles the major competitors in the area, including AstraZeneca, Bayer Corporation, Boehringer Ingelheim, Eli Lilly, Genentech, GlaxoSmithKline, MedImmune, Merck & Co., Pfizer, Sanofi-Aventis, and Schering-Plough.

The information and analysis presented in this report are based on extensive interviews with senior management of top companies in the respiratory drug market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct interviews with 42 industry executives and product managers to validate and obtain expert opinion on current and future trends in the respiratory market. Interviews were also used to confirm and/or adjust market size estimates, as well as in formulating market projections.

Table of Contents

chapter one: Executive Summary

  • Scope and Methodology
  • Size and Growth of the Market
  • Issues and Trends Affecting Market
  • Leading Competitors

Chapter Two: Introduction

  • Structure and Function of the Respiratory System
  • Mechanics of Breathing
  • Alterations in Pulmonary Function
  • Hypoventilation and Hyperventilation
  • Hypoxemia and Hypoxia

Chapter three: Respiratory Diseases

  • Obstruction from Conditions in the Wall of the Lumen
  • Asthma
  • Acute Bronchitis
  • Chronic Bronchitis

 

  • Obstructions Related to Loss of Lung Parenchyma
    • Emphysema
  • Obstruction of the Airway Lumen
    • Bronchiectasis
    • Bronchiolitis
    • Cystic Fibrosis
    • Croup Syndrome
  • Lung Parenchyma Disorders
    • Diffuse Interstitial Lung Disease
    • Sarcoidosis
    • Occupational Lung Diseases
  • Infection or Inflammation of the Lung
    • Pneumonia
    • Severe Acute Respiratory Syndrome
    • Lung Cancer
    • Respiratory Condition Statistics

    chapter Four: Prescription Anti-Inflammatory Agents (Inhaled Corticosteroids)

    • Description of Products
      • Aerosolized Steroids
      • Nasal Sprays
      • Products in Research and Development
      • Allermist
      • Ciclesonide (Alvesco)
      • Flutiform
    • Market Size and Growth
      • Global Market
      • U.S. Market Analysis
      • Competitive Analysis

    Chapter Five: Prescription Mast Cell Stabilizers, Leukotriene Modifiers, and Other Biological Agents

    • Description of Products
      • Currently Available Products
      • Products in Research and Development
      • Roflumilast
      • PTC 124
    • Market Size and Growth
      • Global Market
      • U.S. Market Analysis
      • Competitive Analysis

    chapter Six: Prescription Antihistamines, Decongestants, Antitussives, and Combinations

    • Description of Products
      • Research and Development
      • Pantanase
      • Xyzal
    • Market Size and Growth
      • Global Market
      • U.S. Market Analysis
    • Competitive Analysis

    Chapter seven: Prescription Bronchodilators

    • Description of Products
      • Sympathomimetic Bronchodilators
      • Methylxanthine Agents
      • Anticholinergic Agents
      • Research and Development
      • Arformoterol
      • Indacaterol
      • LAS34273
    • Market Size and Growth
      • Global Market
      • U.S. Market Analysis
      • Competitive Analysis

    chapter eight: Prescription Lung Fluid Replacement and Mucokinetic Agents

    • Description of Products
    • Research and Development
    • Denufosol
  • Market Size and Growth
    • Global Market
    • U.S. Market Analysis
  • Competitive Analysischapter nine: Other Prescription Respiratory Agents
    • Description of Products
    • Antibiotics
    • Cancer Therapy
  • Research and Development
    • Actimmune
    • Aerugen
    • Alpha-1 Protease Inhibitor (API)
    • Avastin
    • Aztreonam
    • Cethrymycin
    • Erbitux
    • Genasense
    • Hycamtin Oral
    • INS37217 Respiratory
    • Javlor
    • Lapatinib
    • Neovastat
    • Nexavar BAY-43-9006
    • NOV-002
    • Numax
    • Oncophage
    • Orapem
    • Panitumumab
    • PF-3512676 (CPG 7909, Promune)
    • Talabostat
    • Targretin
    • Telavancin
    • Telcyta
    • Tobramycin Dry Powder
    • Tocosol
    • Tygacil
    • Vinorelbine IV
    • Xcytrin
    • Xorane
    • Xyotax
    • Zactima
    • EDP-420
  • Market Size and Growth
    • Global Market
    • U.S. Market Analysis
  • Competitive Analysischapter ten: Issues and Trends
    • Patent Loss
      • Labeling Changes
      • Preferred Drug Listing Problems
      • Resistance Issues and Community-acquired Respiratory Infections.
      • Bad Air Quality and the Elderly
      • New Hope for Emphysema Patients
      • Post-approval Drug Studies Mandatory
      • Orphan Drugs
      • DTC Advertising Turmoil
      • Respiratory Drug Delivery

    chapter eleven: Total Market Summary

    • Overview
    • Market Analysis
    • Competitor Analysis

    chapter twelve: Competitor Profiles

    • AstraZeneca PLC
    • Bayer Corporation
    • Boehringer Ingelheim GmbH
    • Eli Lilly and Company
    • Genentech, Inc.
    • GlaxoSmithKline plc
    • MedImmune, Inc.
    • Merck & Company, Inc.
    • Pfizer, Inc.
    • Sanofi-Aventis
    • Schering-Plough Corporation

    Appendix: Company Directory

    List of Exhibits

    chapter one: Executive Summary

    • Figure 1-1: Market Summary: World Market for Prescription Respiratory Drugs 2000-2010
    • Table 1-1: World Market for Respiratory Drugs; Revenues and Market Share by Leading Participants 2005

    Chapter three: Respiratory Diseases

    • Table 3-1: Worldwide Prevalence of Selected Respiratory Conditions
    • (Asthma, Bronchitis, Emphysema, Cystic Fibrosis, Lung Cancer, Allergic Rhinitis, Influenza, COPD)

    chapter Four: Prescription Anti-Inflammatory Agents (Inhaled Corticosteroids)

    • Table 4-1: Prescription Anti-inflammatory Agents in Development (Product, Indication, Developer, Phase)
    • Table 4-2: The World Market for Prescription Anti-inflammatory Agents
    • Revenues and Growth Rates 2000-2010
    • Figure 4-1: Trending in the World Market for Prescription Anti-Inflammatory Agents 2000-2010
    • Table 4-3: The U.S. Market for Prescription Anti-inflammatory Agents
    • Revenues and Share of World Market 2000-2010
    • Figure 4-2: Trending in the U.S. Market for Prescription Anti-inflammatory
    • Agents 2000-2010
    • Table 4-4: The World Market for Prescription Anti-inflammatory Agents
    • Revenues and Market Share by Leading Supplier 2005

    Chapter Five: Prescription Mast Cell Stabilizers, Leukotriene Modifiers, and Other Biological Agents

    • Table 5-1: Prescription Mast Cell Stabilizers, Leukotriene Modifiers, and
    • Other Biologic Agents in Development (Product, Indication,
    • Developer, Phase)
    • Table 5-2: The World Market for Prescription Mast Stabilizers, Leukotriene Modifiers and Other Biologics, Revenues and Growth Rates
    • 2000-2010
    • Figure 5-1: Trensing in the World Market for Prescription Mast Stabilizers, Leukotriene Modifiers and Other Biologics 2000-2010
    • Table 5-3: The U.S. Market for Prescription Mast Stabilizers, Leukotriene
    • Modifiers and Other Biologics Revenues and Share of World
    • Market 2000-2010
    • Figure 5-2: Trending in the U.S. Market for Prescription Mast Stabilizers, Leukotriene Modifiers and Other Biologics 2000-2010
    • Table 5-4: The World Market for Prescription Mast Stabilizers, Leukotriene Modifiers and Other Biologics Revenues and Market Share by
    • Leading Supplier 2005

    chapter Six: Prescription Antihistamines, Decongestants, Antitussives, and Combinations

    • Table 6-1: Prescription Antihistamines, Decongestants, and Combinations in Development (Product, Indication, Developer, Phase)
    • Table 6-2: The World Market for Prescription Antihistamines and Decongestants, Revenues and Growth Rates 2000-2010
    • Figure 6-1: Trending in the World Market for Prescription Antihistamines and Decongestants 2000-2010
    • Table 6-3: The U.S. Market for Prescription Antihistamines and Decongestants, Revenues and Share of World Market 2000-2010
    • Figure 6-2: Trending in the U.S. Market for Prescription Antihistamines and Decongestants 2000-2010
    • Table 6-4: The World Market for Prescription Antihistamines and Decongestants, Revenues and Market Share by Leading Supplier 2005

    Chapter seven: Prescription Bronchodilators

    • Table 7-1: Prescription Bronchodilators in Development (Product, Indication, Developer, Phase)
    • Table 7-2: The World Market for Prescription Bronchodilators Revenues and Growth Rates 2000-2010
    • Figure 7-1: Trending in the World Market for Prescription Bronchodilators 2000-2010
    • Table 7-3: The U.S. Market for Prescription Bronchodilators Revenues and
    • Share of World Market 2000-2010
    • Figure 7-2: Trending the U.S. Market for Prescription Bronchodilators
    • 2000-2010
    • Table 7-4: The World Market for Prescription Bronchodilators Revenues and Market Share by Leading Supplier 2005

    chapter eight: Prescription Lung Fluid Replacement and Mucokinetic Agents

    • Table 8-1: Prescription Lung Fluid Replacement and Mucokinetic Agents in Development (Product, Indication, Developer, Phase)
    • Table 8-2: The World Market for Prescription Lung Fluid Replacement and Mucokinetic Agents Revenues and Growth Rates 2000-2010
    • Figure 8-1: Trending in the World Market for Prescription Lung Fluid
    • Replacement and Mucokinetic Agents 2000-2010
    • Table 8-3: The U.S. Market for Prescription Lung Fluid Replacement and Mucokinetic Agents Revenues and Share of World Market
    • 2000-2010
    • Figure 8-2: Trending in the U.S. Market for Prescription Lung Fluid
    • Replacement and Mucokinetic Agents 2000-2010
    • Table 8-4: The World Market for Prescription Lung Fluid Replacement and Mucokinetic Agents, Revenues and Market Share by Leading
    • Supplier 2005

    chapter nine: Other Prescription Respiratory Agents

    • Table 9-1: Other Prescription Respiratory Agents in Development (Product, Indication, Developer, Phase)
    • Table 9-2: The World Market for Other Prescription Respiratory Drugs
    • Revenues and Growth Rates 2000-2010
    • Figure 9-1: Trending in the World Market for Other Prescription Respiratory
    • Drugs 2000-2010
    • Table 9-3: The U.S. Market for Other Prescription Respiratory Drugs
    • 2000-2010
    • Figure 9-2: Trending in the U.S. Market for Other Prescription Respiratory
    • Drugs 2000-2010
    • Table 9-4: The World Market for Other Prescription Respiratory Drugs
    • Revenues and Market Share by Leading Supplier 2005

    chapter eleven: Total Market Summary

    • Table 11-1: The World Market for Respiratory Drugs, Revenues by Segment
    • 2000-2010
    • Figure 11-1: Trending in the World Market for Respiratory Drugs by Segment 2000-2010
    • Table 11-2: World Market for Prescription Respiratory Drugs Revenues and Segments of Participation of Leading Suppliers 2005
    • Figure 11-2: World Market for Prescription Respiratory Drugs Market
    • Share by Leading Supplier, 2005

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    Outsourcing in Drug Discovery

    $2,062.00 – $4,152.00
  • Placeholder image

    World Market for Anti-infectives Volume II: The World Market for Antibacterial Medications, The

    $2,500.00 – $5,000.00
  • Placeholder image

    Women’s Health: Worldwide Prescription Drug Markets – 3rd Edition

    $2,812.00 – $5,625.00
  • Placeholder image

    Emerging Cancer Vaccine Market, The

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Blood – The Worldwide Market for Blood Products, Blood Testing, Blood...Biophotonics – A Strategic Assessment of Photonics Technologies for Biomedical...
Scroll to top